Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TReP-132 Inhibitors

Chemical inhibitors of TReP-132 can interfere with its function through various molecular pathways, each employing a different mechanism of action. Compounds such as Wortmannin and LY294002 exert their effects by inhibiting phosphoinositide 3-kinases (PI3Ks), which are crucial for the activation of downstream signaling pathways that TReP-132 may rely on for initiating gene transcription. By hindering PI3K, these agents prevent the activation of Akt, a kinase that can modulate transcription factor activity including that of TReP-132. Rapamycin, targeting the mTOR pathway, can also disrupt processes downstream of PI3K/Akt signaling. The inhibition of mTORC1 by Rapamycin leads to a reduction in protein synthesis and may specifically dampen the activity of proteins like TReP-132 by limiting the cellular resources necessary for their function.

Other inhibitors, such as Trichostatin A, impact TReP-132's ability to regulate gene expression by altering the acetylation status of histones, affecting chromatin structure and thereby the accessibility of TReP-132 to DNA. MEK inhibitors PD98059 and U0126 operate upstream of ERK in the MAPK/ERK pathway, a route often implicated in the regulation of transcription factors. By blocking MEK, these inhibitors can prevent the activation of ERK and consequently the phosphorylation of transcription factors that may interact with or regulate TReP-132's activity. Similarly, SP600125 and SB203580, which inhibit JNK and p38 MAPK respectively, can alter the activity of transcription factors or coactivators that are involved in TReP-132-mediated transcriptional regulation. Compounds like Curcumin and Sanguinarine, known for their NF-κB inhibitory effects, can modulate the transcriptional landscape in which TReP-132 operates. Finally, Apigenin's inhibition of protein kinase C (PKC) and Silibinin's effects on signaling may also indirectly influence TReP-132's role in gene expression by affecting the broader network of transcriptional regulation. Each of these chemical inhibitors, by targeting different nodes in the intricate web of cellular signaling, can modulate the functional activity of TReP-132.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3Ks), which are involved in signaling pathways that lead to cell growth and survival. Inhibition of PI3K can reduce the activity of downstream effectors that may be necessary for the transcriptional activity of TReP-132, thereby inhibiting its functional contribution to cellular processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is another PI3K inhibitor that operates similarly to Wortmannin. By impeding the PI3K/Akt pathway, it can decrease the phosphorylation and activation of factors that could be essential for TReP-132's role in gene expression, thus functionally inhibiting TReP-132.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor, which can downregulate protein synthesis by inhibiting the mTORC1 complex, a downstream target of the PI3K/Akt pathway. Although it generally suppresses protein synthesis, its effect on the mTOR pathway can also specifically inhibit the activity of proteins such as TReP-132 that rely on this pathway for their functions.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor that changes the chromatin structure and can regulate gene expression. It may inhibit the functional activity of TReP-132 by altering the acetylation status of histones associated with the genes that TReP-132 regulates, thereby affecting its ability to access DNA and control transcription.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of MEK, which acts upstream of ERK in the MAPK/ERK pathway. Since TReP-132 activity can be modulated by signaling pathways that affect transcription factors, inhibiting MEK, and thus ERK activation, can prevent the phosphorylation and activation of transcriptional regulators that interact with or modulate TReP-132's function.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is also a MEK inhibitor and functions similarly to PD98059. By blocking MEK, the activation of ERK is prevented. ERK is known to influence various transcription factors and their ability to regulate gene expression. As such, the activity of TReP-132 could be functionally inhibited by U0126 due to the disruption of its associated transcriptional control mechanisms.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is involved in transcription factor regulation and apoptosis. Inhibition of JNK can influence the activity of transcription factors that may work in concert with TReP-132, leading to a functional inhibition of TReP-132's role in gene expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor, and by inhibiting p38, it can affect the activity of transcription factors or coactivators that interact with TReP-132, leading to its functional inhibition. p38 MAPK is involved in the response to stress stimuli and may affect the transcriptional regulatory roles of TReP-132.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin has been shown to inhibit the activity of NF-κB, a transcription factor that can regulate the expression of many genes and is involved in cellular responses to stimuli. By inhibiting NF-κB, Curcumin may functionally inhibit the activity of TReP-132 by altering the transcriptional environment in which TReP-132 operates.

Apigenin

520-36-5sc-3529
sc-3529A
sc-3529B
sc-3529C
sc-3529D
sc-3529E
sc-3529F
5 mg
100 mg
1 g
5 g
25 g
100 g
1 kg
$33.00
$214.00
$734.00
$1151.00
$2348.00
$3127.00
$5208.00
22
(1)

Apigenin is a flavonoid that can inhibit protein kinase C (PKC). Given that PKC can modulate the activity of various transcription factors, the inhibition of PKC by Apigenin could lead to a functional inhibition of TReP-132 by affecting the transcriptional networks in which TReP-132 is involved.